Myron S Kwong, MD
Medical Oncology · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 4
- 1 carrier
- Offices
- 4
- Since medical school
- 28 years
- New York Medical College, 1998
On the public record
- 1 Medical Board action on record
Offices
4 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Hospitals listed: 051589. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kwong’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A86563 · Current
Licensed to practise in California · since 2004 · expires 2028-04-30 · New York Medical College. Board flags: Probation Completed.
Public record actions
| 2010-02-28 | Board disciplineDiscipline | Probation completed. · 03 2005170342 |
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Medical Oncology
Original Medicare doctor bills
$43,611
Medicare paid this office $43,611 for 12 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
12 Original Medicare patients in 2024. Average age 64 · 85 and older 0% · Health risk score 2.18. Above the middle of the specialty; the typical medical oncology clinician is at 2.11.
The office billed $114,139, Medicare allowed $55,222 and paid $43,611; for 362 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 12 | 362 | 64 | 2.18 | $114,139 | $43,611 |
| 2020 | 11 | 1,300 | 64 | 1.94 | $120,634 | $30,479 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Drugs they prescribed that Part D paid
$3,344,233
Pharmacies billed $3,344,233 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 10% of their Part D prescriptions (74 of 779) in 2024. Above the middle of the specialty; the typical medical oncology clinician is at 6%.
518 generic and fewer than 11 brand-name prescriptions · $3,344,233 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tagrisso | 36 | $620,369 | $17,232 |
| Xtandi | 36 | $433,194 | $12,033 |
| Pomalyst | 16 | $398,909 | $24,932 |
| Cabometyx | 15 | $325,139 | $21,676 |
| Piqray | 12 | $284,922 | $23,743 |
See all 27 drugs
| Tagrisso | 36 | $620,369 | $17,232 |
| Xtandi | 36 | $433,194 | $12,033 |
| Pomalyst | 16 | $398,909 | $24,932 |
| Cabometyx | 15 | $325,139 | $21,676 |
| Piqray | 12 | $284,922 | $23,743 |
| Imbruvica | 12 | $212,945 | $17,745 |
| Calquence | 13 | $186,771 | $14,367 |
| Ibrance | 12 | $185,323 | $15,444 |
| Kisqali | 13 | $168,042 | $12,926 |
| Orgovyx | 18 | $46,638 | $2,591 |
| Nivestym | 21 | $16,331 | $778 |
| Abiraterone Acetate | 43 | $6,161 | $143 |
| Dexamethasone | 31 | $738 | $24 |
| Anastrozole | 23 | $644 | $28 |
| Hydrocodone-Acetaminophen | 40 | $610 | $15 |
| Ondansetron | 57 | $475 | $8 |
| Levothyroxine | 27 | $467 | $17 |
| Hydroxyurea | 11 | $464 | $42 |
| Lidocaine-Prilocaine | 19 | $371 | $20 |
| Prednisone | 38 | $342 | $9 |
| Prochlorperazine Maleate | 23 | $339 | $15 |
| Morphine Sulfate | 11 | $192 | $17 |
| Diphenoxylate-Atropine | 11 | $171 | $16 |
| Ondansetron Odt | 12 | $160 | $13 |
| Gabapentin | 12 | $140 | $12 |
| Famotidine | 15 | $126 | $8 |
| Lorazepam | 14 | $77 | $6 |
Year by year
| 2024 | 779 | 172 | 10% (74) | None | $3,344,233 |
| 2023 | 568 | 147 | 7% (41) | None | $2,343,662 |
| 2022 | 788 | 157 | 9% (68) | None | $2,414,510 |
| 2021 | 755 | 135 | 9% (68) | None | $2,157,694 |
| 2020 | 755 | 126 | 7% (55) | None | $2,085,450 |
| 2019 | 709 | 154 | 9% (67) | 35% | $1,967,361 |
| 2018 | 753 | 125 | 10% (72) | None | $2,204,616 |
| 2017 | 858 | 163 | 12% (103) | 29% | $2,016,349 |
| 2016 | 731 | 172 | 10% (76) | None | $1,593,305 |
| 2015 | 718 | 176 | 15% (108) | 23% | $1,082,216 |
| 2014 | 731 | 180 | 15% (106) | 23% | $783,993 |
| 2013 | 760 | 166 | 14% (105) | 24% | $984,537 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Tagrisso | 31 | $511,938 | $16,514 |
| Xtandi | 28 | $316,807 | $11,315 |
| Piqray | 11 | $233,745 | $21,250 |
| Ibrance | 14 | $168,136 | $12,010 |
| Zenpep | 12 | $7,328 | $611 |
| Abiraterone Acetate | 18 | $2,704 | $150 |
| Dronabinol | 14 | $816 | $58 |
| Dexamethasone | 25 | $628 | $25 |
| Lidocaine-Prilocaine | 12 | $570 | $47 |
| Anastrozole | 17 | $443 | $26 |
| Levothyroxine | 20 | $421 | $21 |
| Prochlorperazine Maleate | 23 | $337 | $15 |
| Ondansetron | 34 | $292 | $9 |
| Hydrocodone-Acetaminophen | 16 | $217 | $14 |
| Prednisone | 21 | $198 | $9 |
| Diphenoxylate-Atropine | 12 | $186 | $15 |
| Lorazepam | 19 | $102 | $5 |
| Allopurinol | 14 | $99 | $7 |
2022: 26 drugs
| Tagrisso | 27 | $456,544 | $16,909 |
| Ibrance | 25 | $322,801 | $12,912 |
| Pomalyst | 11 | $238,998 | $21,727 |
| Revlimid | 12 | $188,739 | $15,728 |
| Lenalidomide | 20 | $176,726 | $8,836 |
| Calquence | 11 | $160,845 | $14,622 |
| Xtandi | 14 | $146,434 | $10,460 |
| Nivestym | 35 | $24,175 | $691 |
| Zarxio | 23 | $18,269 | $794 |
| Zenpep | 17 | $10,686 | $629 |
| Abiraterone Acetate | 39 | $5,970 | $153 |
| Dexamethasone | 42 | $2,214 | $53 |
| Ondansetron | 67 | $680 | $10 |
| Prochlorperazine Maleate | 27 | $651 | $24 |
| Hydroxyurea | 13 | $637 | $49 |
| Levothyroxine | 33 | $630 | $19 |
| Acyclovir | 16 | $586 | $37 |
| Hydrocodone-Acetaminophen | 43 | $527 | $12 |
| Bicalutamide | 15 | $486 | $32 |
| Prednisone | 37 | $419 | $11 |
| Potassium Chloride | 22 | $351 | $16 |
| Anastrozole | 13 | $316 | $24 |
| Morphine Sulfate Er | 12 | $142 | $12 |
| Famotidine | 17 | $140 | $8 |
| Lidocaine-Prilocaine | 14 | $121 | $9 |
| Lorazepam | 17 | $92 | $5 |
2021: 24 drugs
| Lenvima | 17 | $489,071 | $28,769 |
| Ibrance | 37 | $466,141 | $12,598 |
| Tagrisso | 14 | $232,319 | $16,594 |
| Imbruvica | 16 | $219,274 | $13,705 |
| Xtandi | 26 | $199,665 | $7,679 |
| Zenpep | 21 | $25,560 | $1,217 |
| Zarxio | 21 | $21,417 | $1,020 |
| Abiraterone Acetate | 45 | $8,774 | $195 |
| Dexamethasone | 44 | $1,979 | $45 |
| Prednisone | 61 | $1,101 | $18 |
| Hydrocodone-Acetaminophen | 52 | $890 | $17 |
| Acyclovir | 16 | $776 | $49 |
| Bicalutamide | 19 | $692 | $36 |
| Hydroxyurea | 11 | $518 | $47 |
| Prochlorperazine Maleate | 22 | $500 | $23 |
| Ondansetron | 42 | $418 | $10 |
| Levothyroxine | 24 | $408 | $17 |
| Anastrozole | 17 | $405 | $24 |
| Letrozole | 11 | $276 | $25 |
| Lidocaine-Prilocaine | 12 | $134 | $11 |
| K-Tab Er | 13 | $133 | $10 |
| Allopurinol | 12 | $124 | $10 |
| Famotidine | 14 | $120 | $9 |
| Lorazepam | 19 | $102 | $5 |
2020: 21 drugs
| Lenvima | 24 | $489,977 | $20,416 |
| Ibrance | 32 | $398,805 | $12,463 |
| Tagrisso | 12 | $196,855 | $16,405 |
| Xtandi | 15 | $147,784 | $9,852 |
| Zarxio | 42 | $74,978 | $1,785 |
| Zenpep | 22 | $23,886 | $1,086 |
| Abiraterone Acetate | 44 | $14,056 | $319 |
| Enoxaparin | 15 | $3,879 | $259 |
| Dexamethasone | 39 | $2,316 | $59 |
| Prednisone | 49 | $929 | $19 |
| Acyclovir | 20 | $914 | $46 |
| Anastrozole | 34 | $852 | $25 |
| Hydroxyurea | 11 | $717 | $65 |
| Diphenoxylate-Atropine | 18 | $518 | $29 |
| Hydrocodone-Acetaminophen | 31 | $488 | $16 |
| Amoxicillin | 12 | $436 | $36 |
| Ondansetron | 46 | $414 | $9 |
| Levothyroxine | 20 | $362 | $18 |
| Bicalutamide | 17 | $295 | $17 |
| Lidocaine-Prilocaine | 16 | $245 | $15 |
| K-Tab Er | 11 | $151 | $14 |
2019: 22 drugs
| Tagrisso | 29 | $434,167 | $14,971 |
| Pomalyst | 18 | $337,266 | $18,737 |
| Ibrance | 25 | $309,156 | $12,366 |
| Lenvima | 12 | $193,508 | $16,126 |
| Xtandi | 23 | $181,970 | $7,912 |
| Zarxio | 30 | $46,616 | $1,554 |
| Creon | 12 | $15,662 | $1,305 |
| Abiraterone Acetate | 14 | $15,014 | $1,072 |
| Enoxaparin | 19 | $3,037 | $160 |
| Dexamethasone | 39 | $2,175 | $56 |
| Anastrozole | 41 | $968 | $24 |
| Dronabinol | 12 | $962 | $80 |
| Prednisone | 36 | $551 | $15 |
| Ondansetron | 55 | $463 | $8 |
| Acyclovir | 15 | $377 | $25 |
| Ondansetron Odt | 12 | $364 | $30 |
| Hydrocodone-Acetaminophen | 31 | $359 | $12 |
| Lidocaine-Prilocaine | 21 | $334 | $16 |
| Prochlorperazine Maleate | 14 | $260 | $19 |
| Bicalutamide | 16 | $222 | $14 |
| Acetaminophen-Codeine | 12 | $175 | $15 |
| Lorazepam | 14 | $88 | $6 |
2018: 20 drugs
| Tagrisso | 31 | $461,626 | $14,891 |
| Ibrance | 36 | $405,838 | $11,273 |
| Pomalyst | 17 | $298,854 | $17,580 |
| Afinitor | 18 | $255,462 | $14,192 |
| Nexavar | 12 | $164,541 | $13,712 |
| Xtandi | 23 | $149,144 | $6,485 |
| Iressa | 12 | $96,233 | $8,019 |
| Zarxio | 21 | $38,106 | $1,815 |
| Enoxaparin | 34 | $11,466 | $337 |
| Anastrozole | 44 | $1,866 | $42 |
| Dexamethasone | 36 | $1,500 | $42 |
| Megestrol Acetate | 18 | $891 | $50 |
| Prednisone | 30 | $778 | $26 |
| Tamoxifen Citrate | 15 | $764 | $51 |
| Hydrocodone-Acetaminophen | 36 | $736 | $20 |
| Diphenoxylate-Atropine | 12 | $516 | $43 |
| Ondansetron | 37 | $482 | $13 |
| Acyclovir | 13 | $376 | $29 |
| Lorazepam | 23 | $158 | $7 |
| Citalopram Hbr | 13 | $89 | $7 |
2017: 25 drugs
| Tagrisso | 22 | $324,464 | $14,748 |
| Ibrance | 24 | $257,504 | $10,729 |
| Afinitor | 16 | $213,012 | $13,313 |
| Pomalyst | 12 | $195,901 | $16,325 |
| Zytiga | 20 | $176,573 | $8,829 |
| Revlimid | 11 | $144,398 | $13,127 |
| Xtandi | 17 | $138,180 | $8,128 |
| Iressa | 11 | $73,164 | $6,651 |
| Zarxio | 19 | $36,627 | $1,928 |
| Lovenox | 26 | $12,903 | $496 |
| Imatinib Mesylate | 11 | $12,569 | $1,143 |
| Anastrozole | 87 | $2,465 | $28 |
| Megestrol Acetate | 32 | $1,788 | $56 |
| Tamoxifen Citrate | 28 | $1,309 | $47 |
| Hydroxyurea | 15 | $1,177 | $78 |
| Dexamethasone | 40 | $1,014 | $25 |
| Prednisone | 38 | $866 | $23 |
| Hydrocodone-Acetaminophen | 40 | $820 | $20 |
| Ondansetron | 34 | $718 | $21 |
| Bicalutamide | 19 | $540 | $28 |
| Oxycodone-Acetaminophen | 15 | $430 | $29 |
| Lactulose | 17 | $383 | $23 |
| Lorazepam | 36 | $277 | $8 |
| Acetaminophen-Codeine | 14 | $223 | $16 |
| Lidocaine-Prilocaine | 11 | $215 | $20 |
2016: 26 drugs
| Ibrance | 17 | $188,419 | $11,083 |
| Nexavar | 13 | $183,801 | $14,139 |
| Pomalyst | 13 | $175,631 | $13,510 |
| Xtandi | 17 | $156,133 | $9,184 |
| Gleevec | 15 | $145,498 | $9,700 |
| Gilotrif | 18 | $129,335 | $7,185 |
| Tarceva | 16 | $104,038 | $6,502 |
| Zarxio | 13 | $27,403 | $2,108 |
| Lovenox | 22 | $12,323 | $560 |
| Anastrozole | 108 | $3,696 | $34 |
| Megestrol Acetate | 24 | $2,145 | $89 |
| Tamoxifen Citrate | 22 | $1,213 | $55 |
| Hydrocodone-Acetaminophen | 26 | $898 | $35 |
| Bicalutamide | 23 | $793 | $34 |
| Gabapentin | 14 | $698 | $50 |
| Hydroxyurea | 11 | $568 | $52 |
| Prednisone | 22 | $543 | $25 |
| Ondansetron | 29 | $467 | $16 |
| Acetaminophen-Codeine | 20 | $445 | $22 |
| Morphine Sulfate Er | 12 | $444 | $37 |
| Lactulose | 18 | $366 | $20 |
| Prochlorperazine Maleate | 24 | $362 | $15 |
| Allopurinol | 11 | $218 | $20 |
| Lorazepam | 26 | $192 | $7 |
| Lidocaine-Prilocaine | 11 | $182 | $17 |
| Venlafaxine | 11 | $181 | $16 |
2015: 22 drugs
| Gleevec | 20 | $261,738 | $13,087 |
| Revlimid | 14 | $149,058 | $10,647 |
| Nexavar | 11 | $148,804 | $13,528 |
| Xtandi | 17 | $144,121 | $8,478 |
| Oxycodone | 21 | $10,182 | $485 |
| Lovenox | 11 | $5,444 | $495 |
| Anastrozole | 105 | $3,550 | $34 |
| Megestrol Acetate | 37 | $3,393 | $92 |
| Fentanyl | 15 | $2,972 | $198 |
| Tamoxifen Citrate | 24 | $1,415 | $59 |
| Gabapentin | 11 | $1,271 | $116 |
| Morphine Sulfate Er | 14 | $1,104 | $79 |
| Hydrocodone-Acetaminophen | 19 | $960 | $51 |
| Hydroxyurea | 15 | $849 | $57 |
| Prednisone | 28 | $669 | $24 |
| Lactulose | 27 | $543 | $20 |
| Dexamethasone | 14 | $440 | $31 |
| Prochlorperazine Maleate | 20 | $372 | $19 |
| Acetaminophen-Codeine | 14 | $303 | $22 |
| Lidocaine-Prilocaine | 11 | $255 | $23 |
| Alendronate | 12 | $179 | $15 |
| Lorazepam | 19 | $165 | $9 |
2014: 17 drugs
| Gleevec | 24 | $220,911 | $9,205 |
| Neupogen | 16 | $34,426 | $2,152 |
| Lovenox | 18 | $15,235 | $846 |
| Anastrozole | 104 | $3,575 | $34 |
| Megestrol Acetate | 39 | $3,459 | $89 |
| Tamoxifen Citrate | 23 | $1,345 | $58 |
| Morphine Sulfate Er | 11 | $1,139 | $104 |
| Hydrocodone-Acetaminophen | 58 | $931 | $16 |
| Bicalutamide | 16 | $670 | $42 |
| Prednisone | 38 | $644 | $17 |
| Morphine Sulfate | 13 | $563 | $43 |
| Lactulose | 21 | $422 | $20 |
| Prochlorperazine Maleate | 22 | $374 | $17 |
| Ondansetron | 13 | $293 | $23 |
| Alendronate | 20 | $285 | $14 |
| Lorazepam | 29 | $239 | $8 |
| Citalopram Hbr | 11 | $115 | $10 |
2013: 17 drugs
| Revlimid | 27 | $264,657 | $9,802 |
| Zytiga | 25 | $142,279 | $5,691 |
| Xtandi | 17 | $133,954 | $7,880 |
| Nexavar | 22 | $133,197 | $6,054 |
| Gleevec | 13 | $93,488 | $7,191 |
| Neupogen | 16 | $44,271 | $2,767 |
| Anastrozole | 98 | $3,696 | $38 |
| Megestrol Acetate | 21 | $1,832 | $87 |
| Hydrocodone-Acetaminophen | 54 | $1,020 | $19 |
| Morphine Sulfate Er | 15 | $1,003 | $67 |
| Tamoxifen Citrate | 15 | $959 | $64 |
| Prednisone | 52 | $758 | $15 |
| Prochlorperazine Maleate | 42 | $672 | $16 |
| Lactulose | 22 | $435 | $20 |
| Alendronate | 22 | $350 | $16 |
| Lorazepam | 33 | $338 | $10 |
| Acyclovir | 13 | $292 | $22 |
Money from drug and device companies
$125 in 2019
A payment is not proof that care is biased.
| Alexion Pharmaceuticals | Soliris | $125 | 1 payment
|
See the published payment
| Alexion Pharmaceuticals | Meals · 2019-04-30 | Soliris | $125 |
Professional record
- NPI
- 1992881403
- Licence
- CA A86563California A86563: Current · expires 2028-04-30
- Trained
- New York Medical College, 1998 · 28 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A865630
- Taxonomy
- Federal specialty code 207RH0003X (207RH0003X)
- Mailing address
- 1800 Harrison St Fl 7, Oakland, CA, 94612
- NPI first listed
- 2006-10-27
- NPI last updated
- 2021-12-13
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.